Tirzepatide, a revolutionary treatment for type 2 diabetes, has emerged as a significant advancement in the management of this chronic condition. Marketed by Eli Lilly under the name Mounjaro, it is the first therapeutic agent to concurrently target the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This dual-action mechanism significantly enhances glucose regulation […]
Category: Synthetic Biology
AI’s Top 15: Biotech’s Drug Discovery Leaders
In 2024, artificial intelligence (AI) is revolutionizing biotechnology, particularly in drug discovery. AI is reshaping the development of new therapies, making personalized medicine increasingly achievable. This article highlights fifteen leading AI-enabled biotech companies driving these healthcare advancements.
Onego Bio’s Leap in Animal-Free Egg Production
Onego Bio Secures $40M Funding: In a major advancement, Onego Bio has successfully concluded a $40 million Series A funding, aimed at scaling its groundbreaking animal-free egg protein, Bioalbumen®. This represents a significant milestone in the Nordics, cumulatively raising Onego’s funds to $56M. Key Recent Highlights: Leadership in Precision Fermentation: With this investment, Onego Bio […]